20/20 GeneSystems, Inc.
Gaithersburg, MD · CIK 0001139685 · Medtech · Private
AI-powered laboratory blood tests for early detection of cancers and chronic diseases
2020biolabs.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $4.1M
- 3 Form D · Feb 2025
- 19 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 14
- 6 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,037,014 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $70,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1095 | Motus GI Holdings, Inc. | — | $26M |
| 1096 | Zerigo Health, Inc. | — | $65M |
| 1097 | Mirvie | — | $24M |
| 1098 | 20/20 GeneSystems, Inc. | — | $4.1M |
| 1099 | Radwave Technologies Inc. | — | $4.0M |
| 1100 | ReddyPort, Inc. | — | $3.1M |
| 1101 | Eave, Inc. | — | $7.3M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jonathan CohenDirector · Executive Officer
- Richard CohenDirector
- John ComptonDirector
- Dean HautamakiDirector
- Michael HertzbergDirector
- Joel KanterDirector · Executive Officer
- Vladimir KnezevicDirector
- Wei LuDirector
- Caroline PopperDirector
- Prasanth ReddyDirector
- John RollinsDirector
- Michael RossDirector
- Anne ShiflettExecutive Officer
- Larry ShulmanDirector
- Donald WallachDirector
- Jiminy ZhouExecutive Officer
Patents
- Methods And Machine Learning Systems For Predicting The Likelihood Or Risk Of Having Cancergranted
- Methods And Algorithms For Aiding In The Detection Of Cancergranted
- Methods And Machine Learning Systems For Predicting The Likelihood Or Risk Of Having Cancergranted
- Method For Increasing Available Protein From Endospores For Detection Purposesgranted
- Cancer Classifier Models, Machine Learning Systems And Methods Of Useapplication
- Methods And Compositions For Aiding In Distinguishing Between Benign And Maligannt Radiographically Apparent Pulmonary Nodulesapplication
- Methods And Algorithms For Aiding In The Detection Of Cancergranted
- Methods For Predicting Tumor Response To Targeted Therapiesapplication
- Methods And Algorithms For Aiding In The Detection Of Cancergranted
- Method For Increasing Available Protein From Endospores For Detection Purposesapplication
- Oligonucleotide-coated Affinity Membranes And Uses Thereofapplication
- Rapid Assay, Method And System For Detecting Biowarfare Agentsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.